The four mammalian splice variants encoded by the p21-activated kinase 3 gene have different biological properties

Journal of Neurochemistry

Volumn 106, Issue 3, 2008, Pages 1184-1197

  Kreis, Patricia ^a   Rousseau, Véronique ^a   Thévenot, Emmanuel ^a   Combeau, Gaëlle ^a   Barnier, Jean Vianney ^a  

^a LABORATOIRE DE NEUROBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

Author keywords

Kinase; Mental retardation; p21 activated kinase; Signalization; Splice variant

Indexed keywords

GENE PRODUCT; GUANOSINE TRIPHOSPHATASE; P21 ACTIVATED KINASE 3;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CELL STRUCTURE; CHICKEN; ENZYME ACTIVITY; EXON; EXON B; EXON C; FISH; GENE; HUMAN; MAMMAL; MENTAL DEFICIENCY; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ORYZIAS; PAK3 GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; XENOPUS;

ALTERNATIVE SPLICING; AMINO ACID SUBSTITUTION; ANIMALS; CERCOPITHECUS AETHIOPS; CHICKENS; COS CELLS; HUMANS; MICE; ORYZIAS; P21-ACTIVATED KINASES; PROTEIN ISOFORMS; RATS; SPECIES SPECIFICITY; TETRAODONTIFORMES; XENOPUS LAEVIS;

MAMMALIA; TETRAPODA;

EID: 48249105489     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05474.x     Document Type: Article

References (44)

1. Allen K. M., Gleeson J. G., Bagrodia S., Partington M. W., MacMillan J. C., Cerione R. A., Mulley J. C. Walsh C. A. (1998) PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet. 20, 25 30.
2. Ast G. (2004) How did alternative splicing evolve? Nat. Rev. Genet. 5, 773 782.
3. Bagrodia S., Taylor S. J., Creasy C. L., Chernoff J. Cerione R. A. (1995) Identification of a mouse p21Cdc42/Rac activated kinase published erratum appears in J. Biol. Chem. 1996; 271(2), 1250 J. Biol. Chem. 270, 22731 22737.
4. Barnier J. V., Papin C., Eychene A., Lecoq O. Calothy G. (1995) The mouse B-raf gene encodes multiple protein isoforms with tissue- specific expression. J. Biol. Chem. 270, 23381 23389.
5. Bienvenu T., des Portes V., McDonell N. et al. (2000) Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am. J. Med. Genet. 93, 294 298.
6. Boda B., Alberi S., Nikonenko I., Node-Langlois R., Jourdain P., Moosmayer M., Parisi-Jourdain L. Muller D. (2004) The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus. J. Neurosci. 24, 10816 10825.
7. Boda B., Nikonenko I., Alberi S. Muller D. (2006) Central nervous system functions of PAK protein family: from spine morphogenesis to mental retardation. Mol. Neurobiol. 34, 67 80.
8. Bokoch G. M. (2003) Biology of the p21-activated kinases. Annu. Rev. Biochem. 72, 743 781.
9. Bryan B., Kumar V., Stafford L. J., Cai Y., Wu G. Liu M. (2004) GEFT, a Rho family guanine nucleotide exchange factor, regulates neurite outgrowth and dendritic spine formation. J. Biol. Chem. 279, 45824 45832.
10. Burbelo P. D., Drechsel D. Hall A. (1995) A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. J. Biol. Chem. 270, 29071 29074.
11. Cahoy J. D., Emery B., Kaushal A. et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264 278.
12. Cobos I., Borello U. Rubenstein J. L. (2007) Dlx transcription factors promote migration through repression of axon and dendrite growth. Neuron 54, 873 888.
13. Dan I., Watanabe N. M. Kusumi A. (2001) The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol. 11, 220 230.
14. Gedeon A. K., Nelson J., Gecz J. Mulley J. C. (2003) X-linked mild non-syndromic mental retardation with neuropsychiatric problems and the missense mutation A365E in PAK3. Am. J. Med. Genet. 120A, 509 517.
15. Goslin K., Asmussen H. Banker G. (1998) Culturing Nerve Cells, 2nd Edn. MIT Press, Cambridge, MA, pp. 339 370.
16. Govek E. E., Newey S. E. Van Aelst L. (2005) The role of the Rho GTPases in neuronal development. Genes Dev. 19, 1 49.
17. Greenman C., Stephens P., Smith R. et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446, 153 158.
18. Hayashi M. L., Choi S. Y., Rao B. S., Jung H. Y., Lee H. K., Zhang D., Chattarji S., Kirkwood A. Tonegawa S. (2004) Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice. Neuron 42, 773 787.
19. Hayashi K., Ohshima T., Hashimoto M. Mikoshiba K. (2007) Pak1 regulates dendritic branching and spine formation. Dev. Neurobiol. 67, 655 669.
20. Hofmann C., Shepelev M. Chernoff J. (2004) The genetics of Pak. J. Cell Sci. 117, 4343 4354.
21. Kreis P., Thevenot E., Rousseau V., Boda B., Muller D. Barnier J. V. (2007) The p21-activated kinase 3 implicated in mental retardation regulates spine morphogenesis through a Cdc42-dependent pathway. J. Biol. Chem. 282, 21497 21506.
22. Kumar R., Gururaj A. E. Barnes C. J. (2006) p21-Activated kinases in cancer. Nat. Rev. Cancer 6, 459 471.
23. Lei M., Lu W., Meng W., Parrini M. C., Eck M. J., Mayer B. J. Harrison S. C. (2000) Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell 102, 387 397.
24. Licatalosi D. D. Darnell R. B. (2006) Splicing regulation in neurologic disease. Neuron 52, 93 101.
25. Manser E., Chong C., Zhao Z. S., Leung T., Michael G., Hall C. Lim L. (1995) Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J. Biol. Chem. 270, 25070 25078.
26. Manser E., Huang H. Y., Loo T. H., Chen X. Q., Dong J. M., Leung T. Lim L. (1997) Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol. Cell. Biol. 17, 1129 1143.
27. McCawley L. J., Li S., Wattenberg E. V. Hudson L. G. (1999) Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem. 274, 4347 4353.
28. McPhie D. L., Coopersmith R., Hines-Peralta A., Chen Y., Ivins K. J., Manly S. P., Kozlowski M. R., Neve K. A. Neve R. L. (2003) DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J. Neurosci. 23, 6914 6927.
29. Meng J., Meng Y., Hanna A., Janus C. Jia Z. (2005) Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. J. Neurosci. 25, 6641 6650.
30. Papin C., Denouel-Galy A., Laugier D., Calothy G. Eychene A. (1998) Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf. J. Biol. Chem. 273, 24939 24947.
31. Peippo M., Koivisto A. M., Sarkamo T., Sipponen M., von Koskull H., Ylisaukko-Oja T., Rehnstrom K., Froyen G., Ignatius J. Jarvela I. (2007) PAK3 related mental disability: further characterization of the phenotype. Am. J. Med. Genet. 143A, 2306 2316.
32. Rao N., Nguyen S., Ngo K. Fung-Leung W. P. (2005) A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol. Cell. Biol. 25, 6521 6532.
33. Rousseau V., Goupille O., Morin N. Barnier J. V. (2003) A new constitutively active brain PAK3 isoform displays modified specificities toward Rac and Cdc42 GTPases. J. Biol. Chem. 278, 3912 3920.
34. Sells M. A., Knaus U. G., Bagrodia S., Ambrose D. M., Bokoch G. M. Chernoff J. (1997) Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7, 202 210.
35. Sells M. A., Pfaff A. Chernoff J. (2000) Temporal and spatial distribution of activated Pak1 in fibroblasts. J. Cell Biol. 151, 1449 1458.
36. Souopgui J., Solter M. Pieler T. (2002) XPak3 promotes cell cycle withdrawal during primary neurogenesis in Xenopus laevis. EMBO J. 21, 6429 6439.
37. Toutant M., Costa A., Studler J. M., Kadare G., Carnaud M. Girault J. A. (2002) Alternative splicing controls the mechanisms of FAK autophosphorylation. Mol. Cell. Biol. 22, 7731 7743.
38. Tsuiki H., Tnani M., Okamoto I., Kenyon L. C., Emlet D. R., Holgado-Madruga M., Lanham I. S., Joynes C. J., Vo K. T. Wong A. J. (2003) Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors. Cancer Res. 63, 250 255.
39. Tu H. Wigler M. (1999) Genetic evidence for Pak1 autoinhibition and its release by Cdc42. Mol. Cell. Biol. 19, 602 611.
40. Ule J. Darnell R. B. (2006) RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr. Opin. Neurobiol. 16, 102 110.
41. Vignal E., De Toledo M., Comunale F., Ladopoulou A., Gauthier-Rouviere C., Blangy A. Fort P. (2000) Characterization of TCL, a new GTPase of the rho family related to TC10 and Ccdc42. J. Biol. Chem. 275, 36457 36464.
42. Zhang H., Webb D. J., Asmussen H., Niu S. Horwitz A. F. (2005) A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J. Neurosci. 25, 3379 3388.
43. Zhao Z. S., Manser E., Chen X. Q., Chong C., Leung T. Lim L. (1998) A conserved negative regulatory region in alphaPAK: inhibition of PAK kinases reveals their morphological roles downstream of Cdc42 and Rac1. Mol. Cell. Biol. 18, 2153 2163.
44. Zhao L., Ma Q. L., Calon F. et al. (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat. Neurosci. 9, 234 242.